Download PDF
Semin Thromb Hemost 2019; 45(08): 778-783
DOI: 10.1055/s-0039-1696942
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Pulmonary Thrombosis: A Clinical Pathological Entity Distinct from Pulmonary Embolism?

Francesco Marongiu
1   Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy
,
Antonella Mameli
1   Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy
,
Elvira Grandone
2   Atherosclerosis and Thrombosis Unit, IRCCS Ospedale Casa Sollievo della Sofferenza, Foggia, Italy
3   Department of Obstetrics and Gynecology, First Moscow State Medical University, Moscow, Russia
,
Doris Barcellona
1   Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
19 September 2019 (online)

   Permissions and Reprints

Abstract

Since Virchow's autopsy studies in the mid-1800s, it has generally been believed that pulmonary embolism (PE) originated from the embolization of fibrin fragments from a deep venous thrombosis (DVT). However, a DVT is often not found in patients with PE (up to 50% of cases). Could fibrin form in the pulmonary vessels without coming from the periphery? In this review, the authors will try to support the hypothesis that a pulmonary thrombosis (PT) may develop. They will do so through different clinical models related to some pathological conditions such as pneumonia, chronic obstructive pulmonary disease (COPD), and asthma, all of which show a close relationship between local inflammation and activation of blood coagulation, two defensive systems that may lead to fibrin deposition in the lungs, thus recognizing the possibility that PT may be a newly recognized entity. An increased risk for PE has been demonstrated in these conditions. Sickle cell disease and assisted reproductive technologies are other very different conditions in which an increased risk for PE has been found. Gaucher's disease is a rare hereditary condition in which the hemostatic system could have a role in the pathogenesis of pulmonary hypertension, which complicates the course of the disease. In particular, the increased risk for PT, common to all these conditions, deserves attention when a patient presents with sudden dyspnea, an unexpected COPD exacerbation, or severe sudden asthmatic dyspnea. As a consequence, prediction scores for venous thromboembolism could be revised.

Keywords

pulmonary embolism - pulmonary thrombosis - pneumonia - chronic obstructive pulmonary disease - asthma - sickle cell disease - Gaucher's disease
 

  • References

  • 1 Jiménez D, Aujesky D, Díaz G. , et al; RIETE Investigators. Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med 2010; 181 (09) 983-991
    CrossrefPubMedSearch in Google Scholar
  • 2 Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Presence of lower limb deep vein thrombosis and prognosis in patients with symptomatic pulmonary embolism: preliminary report. Eur J Vasc Endovasc Surg 2009; 37 (02) 225-231
    CrossrefPubMedSearch in Google Scholar
  • 3 Ribeiro DD, Lijfering WM, Van Hylckama Vlieg A, Rosendaal FR, Cannegieter SC. Pneumonia and risk of venous thrombosis: results from the MEGA study. J Thromb Haemost 2012; 10 (06) 1179-1182
    CrossrefPubMedSearch in Google Scholar
  • 4 Hess R, Wujak L, Hesse C. , et al. Coagulation factor XII regulates inflammatory responses in human lungs. Thromb Haemost 2017; 117 (10) 1896-1907
    Thieme ConnectPubMedSearch in Google Scholar
  • 5 Levi M, Schultz MJ, Rijneveld AW, van der Poll T. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med 2003; 31 (4, Suppl): S238-S242
    CrossrefPubMedSearch in Google Scholar
  • 6 Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS. Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia--a review. Crit Care Med 2006; 34 (03) 871-877
    CrossrefPubMedSearch in Google Scholar
  • 7 Stroo I, Ding C, Novak A. , et al. Inhibition of the extrinsic or intrinsic coagulation pathway during pneumonia-derived sepsis. Am J Physiol Lung Cell Mol Physiol 2018; 315 (05) L799-L809
    CrossrefPubMedSearch in Google Scholar
  • 8 Claushuis TA, de Stoppelaar SF, Stroo I. , et al. Thrombin contributes to protective immunity in pneumonia-derived sepsis via fibrin polymerization and platelet-neutrophil interactions. J Thromb Haemost 2017; 15 (04) 744-757
    CrossrefPubMedSearch in Google Scholar
  • 9 Antoniak S. The coagulation system in host defense. Res Pract Thromb Haemost 2018; 2 (03) 549-557
    CrossrefPubMedSearch in Google Scholar
  • 10 Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care 2003; 48 (12) 1204-1213 , discussion 1213–1215
    PubMedSearch in Google Scholar
  • 11 Paliogiannis P, Fois AG, Sotgia S. , et al. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives. Eur Respir Rev 2018; 27 (147) 170113
    CrossrefPubMedSearch in Google Scholar
  • 12 Brinkmann V, Reichard U, Goosmann C. , et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303 (5663): 1532-1535
    CrossrefPubMedSearch in Google Scholar
  • 13 Porto BN, Stein RT. Neutrophil extracellular traps in pulmonary diseases: too much of a good thing?. Front Immunol 2016; 7: 311
    PubMedSearch in Google Scholar
  • 14 Kapoor S, Opneja A, Nayak L. The role of neutrophils in thrombosis. Thromb Res 2018; 170: 87-96
    CrossrefPubMedSearch in Google Scholar
  • 15 Schneider C, Bothner U, Jick SS, Meier CR. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol 2010; 25 (04) 253-260
    CrossrefPubMedSearch in Google Scholar
  • 16 Tillie-Leblond I, Marquette CH, Perez T. , et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med 2006; 144 (06) 390-396
    PubMedSearch in Google Scholar
  • 17 Sidney S, Sorel M, Quesenberry Jr CP, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128 (04) 2068-2075
    CrossrefPubMedSearch in Google Scholar
  • 18 Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet 2018; 391 (10122): 783-800
    CrossrefPubMedSearch in Google Scholar
  • 19 Wanner A, Mendes ES. Airway endothelial dysfunction in asthma and chronic obstructive pulmonary disease: a challenge for future research. Am J Respir Crit Care Med 2010; 182 (11) 1344-1351
    CrossrefPubMedSearch in Google Scholar
  • 20 Majoor CJ, Kamphuisen PW, Zwinderman AH. , et al. Risk of deep vein thrombosis and pulmonary embolism in asthma. Eur Respir J 2013; 42 (03) 655-661
    CrossrefPubMedSearch in Google Scholar
  • 21 Zöller B, Pirouzifard M, Memon AA, Sundquist J, Sundquist K. Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case-control study from Sweden. Eur Respir J 2017; 49 (02) 1601014
    CrossrefPubMedSearch in Google Scholar
  • 22 Franck PFH, Bevers EM, Lubin BH. , et al. Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells. J Clin Invest 1985; 75 (01) 183-190
    CrossrefPubMedSearch in Google Scholar
  • 23 Chiu D, Lubin B, Roelofsen B, van Deenen LL. Sickled erythrocytes accelerate clotting in vitro: an effect of abnormal membrane lipid asymmetry. Blood 1981; 58 (02) 398-401
    CrossrefPubMedSearch in Google Scholar
  • 24 Westerman MP, Green D, Gilman-Sachs A. , et al. Coagulation changes in individuals with sickle cell trait. Am J Hematol 2002; 69 (02) 89-94
    CrossrefPubMedSearch in Google Scholar
  • 25 Setty BN, Rao AK, Stuart MJ. Thrombophilia in sickle cell disease: the red cell connection. Blood 2001; 98 (12) 3228-3233
    CrossrefPubMedSearch in Google Scholar
  • 26 Stein PD, Beemath A, Meyers FA, Skaf E, Olson RE. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med 2006; 119 (10) 897.e7-897.e11
    CrossrefPubMedSearch in Google Scholar
  • 27 Austin H, Key NS, Benson JM. , et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 2007; 110 (03) 908-912
    PubMedSearch in Google Scholar
  • 28 Naik RP, Smith-Whitley K, Hassell KL. , et al. Clinical outcomes associated with sickle cell trait: a systematic review. Ann Intern Med 2018; 169 (09) 619-627
    CrossrefPubMedSearch in Google Scholar
  • 29 Noubiap JJ, Temgoua MN, Tankeu R, Tochie JN, Wonkam A, Bigna JJ. Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis. Thromb J 2018; 16: 27
    CrossrefPubMedSearch in Google Scholar
  • 30 Stirnemann J, Belmatoug N, Camou F. , et al. A review of Gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci 2017; 18 (02) E441
    CrossrefPubMedSearch in Google Scholar
  • 31 Jmoudiak M, Futerman AH. Gaucher disease: pathological mechanisms and modern management. Br J Haematol 2005; 129 (02) 178-188
    CrossrefPubMedSearch in Google Scholar
  • 32 Lee S, Mark A, Huen K. , et al. Gaucher disease with pulmonary involvement in a 6 years old girl: report of resolution of radiographic abnormalities on increasing dose of imiglucerase. J Pediatr 2001; 139: 862-864
    CrossrefPubMedSearch in Google Scholar
  • 33 Engeler CE, Tashjian JH, Trenkner SW, Walsh JW. Ground-glass opacity of the lung parenchyma: a guide to analysis with high-resolution CT. AJR Am J Roentgenol 1993; 160 (02) 249-251
    CrossrefPubMedSearch in Google Scholar
  • 34 Sherif EM, Tantawy AA, Adly AA, Kader HA, Ismail EA. D-dimer assay in Egyptian patients with Gaucher disease: correlation with bone and lung involvement. Blood Coagul Fibrinolysis 2011; 22 (03) 176-184
    CrossrefPubMedSearch in Google Scholar
  • 35 Shitrit D, Rudensky B, Zimran A, Elstein D. D-dimer assay in Gaucher disease: correlation with severity of bone and lung involvement. Am J Hematol 2003; 73 (04) 236-239
    CrossrefPubMedSearch in Google Scholar
  • 36 Chan WS, Dixon ME. The “ART” of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res 2008; 121 (06) 713-726
    CrossrefPubMedSearch in Google Scholar
  • 37 Grandone E, Di Micco PP, Villani M. , et al; RIETE Investigators. Venous thromboembolism in women undergoing assisted reproductive technologies: data from the RIETE Registry. Thromb Haemost 2018; 118 (11) 1962-1968
    Thieme ConnectPubMedSearch in Google Scholar
  • 38 Mameli A, Palmas MA, Antonelli A, Contu P, Prandoni P, Marongiu F. A retrospective cohort study of patients with pulmonary embolism: the impact of comorbidities on patient's outcome. Eur Respir J 2016; 48 (02) 555-557
    CrossrefPubMedSearch in Google Scholar
  • 39 van Langevelde K, Flinterman LE, van Hylckama Vlieg A, Rosendaal FR, Cannegieter SC. Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. Blood 2012; 120 (05) 933-946
    PubMedSearch in Google Scholar
  • 40 Lensing AW, Doris CI, McGrath FP. , et al. A comparison of compression ultrasound with color Doppler ultrasound for the diagnosis of symptomless postoperative deep vein thrombosis. Arch Intern Med 1997; 157 (07) 765-768
    CrossrefPubMedSearch in Google Scholar
  • 41 Stern JB, Abehsera M, Grenet D. , et al. Detection of pelvic vein thrombosis by magnetic resonance angiography in patients with acute pulmonary embolism and normal lower limb compression ultrasonography. Chest 2002; 122 (01) 115-121
    CrossrefPubMedSearch in Google Scholar
  • 42 Kearon C. Diagnosis of suspected venous thromboembolism. Hematology (Am Soc Hematol Educ Program) 2016; 2016 (01) 397-403
    CrossrefPubMedSearch in Google Scholar
  • 43 van Langevelde K, Srámek A, Vincken PW, van Rooden JK, Rosendaal FR, Cannegieter SC. Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique. Haematologica 2013; 98 (02) 309-315
    CrossrefPubMedSearch in Google Scholar
  • 44 Kelly J, Hunt BJ, Moody A. Magnetic resonance direct thrombus imaging: a novel technique for imaging venous thromboemboli. Thromb Haemost 2003; 89 (05) 773-782
    Thieme ConnectPubMedSearch in Google Scholar
  • 45 Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 1991; 302 (6778): 709-711
    CrossrefPubMedSearch in Google Scholar
  • 46 Gerotziafas GT, Papageorgiou L, Salta S, Nikolopoulou K, Elalamy I. Updated clinical models for VTE prediction in hospitalized medical patients. Thromb Res 2018; 164 (Suppl. 01) S62-S69
    CrossrefPubMedSearch in Google Scholar
  • 47 Nakazawa T, Watanabe Y, Hori Y. , et al. Lung perfused blood volume images with dual-energy computed tomography for chronic thromboembolic pulmonary hypertension: correlation to scintigraphy with single-photon emission computed tomography. J Comput Assist Tomogr 2011; 35 (05) 590-595
    CrossrefPubMedSearch in Google Scholar